Singular Genomics Systems, Inc. 3 SEC Filings

Filed On	Filing
18 Sep 2024	Form 3: Tang Kevin, 10% owner and 2 others Holds 249,584 shares of Common Stock
09 Nov 2023	Form 3: Ghai Jyotsna, Chief Operating Officer Holds 3,000 shares of Common Stock
08 Aug 2023	Form 3: Eisenberg Marcia, Director No securities owned
20 Apr 2023	Form 3: Ropp Sam, Chief Commercial Officer
06 Jan 2022	Form 3: Mardis Elaine R, Director No securities owned
26 May 2021	Form 3: Alexandria Venture Investments, Llc, 10% owner
26 May 2021	Form 3: Spaventa Andrew, Director Holds 4,613,571 shares of Common Stock
26 May 2021	Form 3: Flynn James E, 10% owner and 5 others
26 May 2021	Form 3: Kamdar Kim P., Director Holds 15,000 shares of Common Stock
26 May 2021	Form 3: Ryan Jason, Director
26 May 2021	Form 3: Pellini Michael J, Director Holds 72,455 shares of Common Stock
26 May 2021	Form 3: Barker David L, Director Holds 1,000,000 shares of Common Stock
26 May 2021	Form 3: Brancaccio Vincent, Vice President, HR Holds 32,500 shares of Common Stock
26 May 2021	Form 3: Meeter Dalen, Vice President, Finance Holds 160,000 shares of Common Stock
26 May 2021	Form 3: Durie Daralyn, General Counsel
26 May 2021	Form 3: Velarde Jorge, Senior Vice President Holds 340,000 shares of Common Stock
26 May 2021	Form 3: Daly David, President and Chief Operating Holds 900,000 shares of Common Stock
26 May 2021	Form 3: Glezer Eli N., Chief Scientific Officer Holds 4,135,000 shares of Common Stock

Comments